Hans Jornvall

Title: The Innovations of Hans Jornvall

Introduction

Hans Jornvall is a notable inventor based in Sweden. He has made significant contributions to the field of biotechnology. His work primarily focuses on the development of nucleic acid molecules and their applications in medical treatments.

Latest Patents

Hans Jornvall holds a patent for "Bis-Met Histones." This invention provides a nucleic acid molecule that encodes a polypeptide consisting of two methionine residues as the first and second N-terminal amino acid residues. These residues are linked via a peptide bond to a mature eukaryotic histone. The invention also includes a vector containing the nucleic acid molecule, a host transformed with the vector, and polypeptides encoded by the nucleic acid molecule. Furthermore, it relates to pharmaceutical and diagnostic compositions. The invention is aimed at the preparation of compositions for the treatment of diseases. Additionally, it includes methods for testing the presence of the nucleic acid molecule or the polypeptide in a sample, along with a kit for such testing.

Career Highlights

Hans Jornvall is associated with Symbiotec Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie mbH. His work at this company has allowed him to explore innovative solutions in biotechnology. Despite having no patents to his name, his research has contributed to advancements in the field.

Collaborations

Some of his notable coworkers include Peter Gross and Michel Thiry. Their collaboration has likely fostered a productive environment for research and development.

Conclusion

Hans Jornvall's contributions to biotechnology, particularly through his patent on Bis-Met Histones, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the field and pave the way for future discoveries.